KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Accumulated Depreciation & Amortization (2016 - 2025)

Elevance Health (ELV) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $3.7 billion as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 3.75% to $3.7 billion in Q4 2024 year-over-year; TTM through Dec 2024 was $3.7 billion, a 3.75% increase, with the full-year FY2024 number at $3.7 billion, up 3.75% from a year prior.
  • Accumulated Depreciation & Amortization was $3.7 billion for Q4 2024 at Elevance Health, up from $3.5 billion in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.3 billion in Q4 2021 to a low of $2.8 billion in Q4 2022.
  • A 5-year average of $3.6 billion and a median of $3.7 billion in 2024 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 35.41% in 2022, then increased 26.44% in 2023.
  • Elevance Health's Accumulated Depreciation & Amortization stood at $3.8 billion in 2020, then grew by 12.9% to $4.3 billion in 2021, then plummeted by 35.41% to $2.8 billion in 2022, then rose by 26.44% to $3.5 billion in 2023, then rose by 3.75% to $3.7 billion in 2024.
  • Per Business Quant, the three most recent readings for ELV's Accumulated Depreciation & Amortization are $3.7 billion (Q4 2024), $3.5 billion (Q4 2023), and $2.8 billion (Q4 2022).